InsidersTradesSigma
Track the 멕아이씨에스 stock price and the full insider trade history of the company, a publicly traded company based in South Korea. Shares are quoted on the KR market, under the oversight of DART (FSS). Operating in the Health Care sector, 멕아이씨에스 has recorded 12 public disclosures. Market capitalisation: €25.9bn. The latest transaction was filed on 16 June 2026 (Purchase). Among the most active insiders: 오정택. Every trade is openly available.
10
Insider Decl.
n/a
Thresholds
n/a
7 ops.
Buy Volume
n/a
n/a
Sell Volume
Fundamental score
Ranked 24,232 of 29,156 companies
28.3
score / 100
Value16
Quality40
FCF yld-9.9%
Earn yld-9.8%
EV/EBITDA·
ROE·
Gross mgn55%
Net mgn-22%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 16 June 2026
Declarations12 total
Other
Other
12 of 12 declarations
About 멕아이씨에스
멕아이씨에스 is a company operating in the healthcare and pharmaceutical sector, listed on the XKRX. It specializes in developing innovative solutions for the medical field.